Skip to main content
. 2019 Jul 17;17(4):1038–1043. doi: 10.5114/aoms.2019.86622

Figure 2.

Figure 2

Knockdown of miR-130b reduced IC50 of doxorubicin in doxorubicin-resistant cells. *p < 0.05 vs. blank control or miR-NC(–) group